Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients.
Roussel-Robert
V
V
Torchet
M F
MF
Legrand
F
F
Rothschild
C
C
Stieltjes
N
N
D000328:Adult; D000368:Aged; D000917:Antibody Formation; D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007518:Isoantibodies / Q000097:blood; D008875:Middle Aged; D010446:Peptide Fragments / Q000276:immunology / Q000627:therapeutic use
C451034:B-domain-deleted factor VIII; D007518:Isoantibodies; D010446:Peptide Fragments; D005169:Factor VIII